Diffusion Pharmaceuticals Stock Price

-0.0017 (-0.66%)
Upgrade to Real-Time
Afterhours (Closed)
Volume 635,288
Bid Price 0.2513
Ask Price 0.2553
News -
Day High 0.26


52 Week Range


Day Low 0.25
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Diffusion Pharmaceuticals Inc DFFN NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.0017 -0.66% 0.2553 19:24:16
Open Price Low Price High Price Close Price Prev Close
0.255 0.25 0.26 0.2529 0.257
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
983 635,288 $ 0.2538947 $ 161,296 - 0.25 - 1.85
Last Trade Time Type Quantity Stock Price Currency
19:24:16 formt 100 $ 0.2553 USD


Draw Mode:

Diffusion Pharmaceuticals Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 26.02M 101.92M 101.77M $ - $ - -0.30 -1.00
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - - 8.30%

more financials information »

Diffusion Pharmaceuticals News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical DFFN Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.27970.29750.250.269685511,580-0.0244-8.72%
1 Month0.36020.38960.250.305468992,993-0.1049-29.12%
3 Months0.450.490.250.37380821,375,390-0.1947-43.27%
6 Months0.550.630.250.44855331,178,044-0.2947-53.58%
1 Year1.14911.850.251.032,821,307-0.8938-77.78%
3 Years2.2111.000.2110.92036792,531,491-1.95-88.45%
5 Years78.00103.950.2112.741,674,795-77.74-99.67%

Diffusion Pharmaceuticals Description

Diffusion Pharmaceuticals Inc is a clinical-stage biotechnology company. It is focused on extending the life expectancy of cancer patients by improving the effectiveness of current standard-of-care treatments, including radiation therapy and chemotherapy. The company's lead product candidate is trans sodium crocetinate (TSC), which is used for the treatment of glioblastoma multiforme (GBM) and metastatic brain cancer.

Your Recent History
Diffusion ..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.